Dr Olivier Tredan
- Spécialité
- Oncologue médical, expert sein et gynécologie
- Titre
- Coordinateur de département
- Hôpital
- Centre Léon Bérard (Lyon)
- Derniers articles
-
- Patient perception on risk of recurrence and decision-making in the management of HER2-positive early breast cancer: Insights from the ASKHER2 European survey. (1 juin 2025)
- Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial. (7 avr. 2025)
- Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trial. (1 avr. 2025)
- Darolutamide or capecitabine in triple-negative, androgen receptor-positive, advanced breast cancer (UCBG 3-06 START): a multicentre, non-comparative, randomised, phase 2 trial. (1 mars 2025)
- Long-term behavioral symptom clusters among survivors of early-stage breast cancer: Development and validation of a predictive model. (1 janv. 2025)